Control of cell proliferation by steroids: The role of 17HSDs

Molecular and Cellular Endocrinology

Volumn 248, Issue 1-2, 2006, Pages 141-148

  Vihko, P ^a,b   Herrala, A ^a   Harkonen P ^a   Isomaa, V ^a   Kaija, H ^a   Kurkela, R ^a   Pulkka, A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

17 Hydroxysteroid dehydrogenase; Androgen; Breast cancer; Estrogen; Prostate cancer

Indexed keywords

ANDROGEN; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; STEROID; TAMOXIFEN; TESTOSTERONE 17BETA DEHYDROGENASE;

ANDROGEN METABOLISM; BREAST CANCER; BREAST TUMOR; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CELL STRAIN LNCAP; CONFERENCE PAPER; GENE EXPRESSION; GROWTH REGULATION; HUMAN; IN SITU HYBRIDIZATION; MALIGNANT TRANSFORMATION; NEUROSECRETORY CELL; NORTHERN BLOTTING; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; STEROID METABOLISM; TUMOR VOLUME;

17-HYDROXYSTEROID DEHYDROGENASES; ANDROGENS; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 33644911450     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.12.005     Document Type: Conference Paper

References (55)

1. T.J. Anderson, D.J.P. Ferguson, and G.M. Raap Cell turnover of the 'resting' human breast: influence of parity, contraceptive pill, age and laterality Brit. J. Cancer 46 1982 376 380
2. F. Berrino, P. Muti, A. Micheli, G. Polelli, V. Krogh, R. Sciajno, P. Pisani, P. Panico, and G. Secreto Serum sex hormone levels after menopause and subsequent breast cancer J. Natl. Cancer Inst. 88 1996 291 296
3. R. Breitling, A. Krazeisen, G. Möller, and J. Adamski 17β-hydroxysteroid dehydrogenase type 7 - an ancient 3-ketosteroid reductase of cholesterogenesis Mol. Cell. Endocrinol. 171 2001 199 204
4. J.F. Couse, and K.S. Korach Estrogen receptor null mice: what have we learned and where they lead us? Endocr. Rev. 20 1999 357 417
5. K.J. Cullen, and M.E. Lippman Estrogen regulation of protein synthesis and cell growth in human breast cancer Vitam. Horm. 45 1989 127 158
6. J.C. Desmond, J.C. Mountford, M.T. Drayson, E.A. Walker, M. Hewison, J.P. Ride, Q.T. Luong, R.E. Hayuden, E.F. Vanin, and C.M. Bunce The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of non-steroidal anti-inflammatory drugs Cancer Res. 63 2003 505 512
7. I. Dufort, P. Rheault, X.F. Huang, P. Soucy, and V. Luu-The Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase Endocrinology 140 1999 568 574
8. J.P. Elo, L.A. Akinola, M. Poutanen, P. Vihko, A.P. Kyllönen, O. Lukkarinen, and R. Vihko Characterization of 17β-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate Int. J. Cancer 66 1996 37 41
9. J.P. Elo, P. Härkönen, A.P. Kyllönen, O. Lukkarinen, M. Poutanen, R. Vihko, and P. Vihko Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer Cancer Res. 57 1997 3356 3359
10. J.P. Elo, P. Härkönen, A.P. Kyllönen, O. Lukkarinen, and P. Vihko Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tomour and poor prognosis for the patient Brit. J. Cancer 79 1999 156 160
11. C. Foster, S. Mäkelä, A. Wärri, S. Kietz, D. Becker, K. Hultenby, M. Warner, and J.Å. Gustafsson Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium Proc. Natl. Acad. Sci. U.S.A. 99 2002 15578 15583
12. N. Fournet-Dulguerov, N.J. MacLusky, C.Z. Leranth, R. Todd, C.R. Mendelson, E.R. Simpson, and F. Naftolin Immunohistochemical localization of aromatase cytochrome P-450 and estradiol dehydrogenase in the syncytiotrophoblast of the human placenta J. Clin. Endocrinol. Metab. 65 1987 757 764
13. W.M. Geissler, D.L. Davis, L. Wu, K.D. Bradshaw, S. Patel, B.B. Mendonca, K.O. Elliston, J.D. Wilson, D.W. Russel, and S. Andersson Male pseudohermaphroditism caused by mutations of the testicular 17β- hydroxysteroid dehydrogenase 3 Nat. Genet. 7 1994 34 39
14. S.A. Ghersevich, M.H. Poutanen, H.K. Martikainen, and R.K. Vihko Expression of 17β-hydroxysteroid dehydrogenase type 1 in human granulosa cells: correlation with follicular size, cytochrome P450 aromatase activity and oestradiol production J. Endocrinol. 143 1994 139 150
15. R.T. Greenlee, B.M. Hill-Hermon, T. Murray, and M. Thun Cancer statistics CA Cancer J. Clin. 51 2001 15 36
16. C. Gunnarsson, B.M. Olson, and O. Stål Members of the Southeast Sweden Breast Cancer Group. Abnormal expression of 17β-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence Cancer Res. 61 2001 8448 8451
17. Gunnarsson, C., Hellqvist, E., Stål, O., and the Southeast Sweden Breast Cancer Group, 2005. 17β-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer. Brit. J. Cancer 92, 547-552.
18. S.E. Hankinson, W.C. Willett, J.E. Manson, G.A. Colditz, D.J. Hunter, D. Spiegelman, R.L. Barbieri, and F.E. Speizer Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women J. Natl. Cancer Inst. 90 1998 1292 1299
19. P. Härkönen, S. Törn, R. Kurkela, K. Porvari, A. Pulkka, A. Lindfors, V. Isomaa, and P. Vihko Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state J. Clin. Endocrinol. Metab. 88 2003 705 712
20. Y. Jin, and T.M. Penning Steroid 5α-reductases and 3α-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism Best Pract. Res. Clin. Endocrinol. Metab. 15 2001 79 94
21. F. Labrie, V. Luu-The, S.X. Lin, C. Labrie, J. Simard, R. Breton, and F. Labrie The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology Steroids 62 1997 148 158
22. T. Lanisnik Rizner, H.K. Lin, D.M. Peehl, S. Steckelbroeck, D.R. Bauman, and T.M. Penning Human type 3 3α-hydroxysteroid dehydrogenate (aldo-keto reductase 1C2) and androgen metabolism in prostate cells Endocrinology 144 2003 2922 2932
23. Y. Li, V. Isomaa, A. Pulkka, R. Herva, H. Peltoketo, and P. Vihko Expression of 3beta-hydroxysteroid dehydrogenase type 1, P450 aromatase, and 17beta-hydroxysteroid dehydrogenase types 1, 2, 5 and 7 mRNAs in human early and mid-gestation placentas Placenta 26 2005 387 392
24. V. Luu-The, I. Dufort, G. Pelletier, and F. Labrie Type 5 17β-hydroxysteroid dehydrogenase: its role in the formation of androgens in women Mol. Cell. Endocrinol. 171 2001 77 82
25. Z. Marijanovic, D. Laubner, G. Möller, C. Gege, B. Hausen, J. Adamski, and R. Breitling Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis Mol. Endocrinol. 17 2003 1715 1725
26. P. Mauvais-Jarvis, F. Kuttenn, and A. Compel Estradiol/progesterone interaction in normal and pathologic breast cells Ann. N.Y. Acad. Sci. 464 1986 152 167
27. M.M. Miettinen, M.H. Poutanen, and R.K. Vihko Characterization of estrogen-dependent growth of cultured MCF-7 human breast-cancer cells expressing 17β-hydroxysteroid dehydrogenase type 1 Int. J. Cancer 68 1996 600 604
28. M.M. Miettinen, M.V. Mustonen, M.H. Poutanen, V.V. Isomaa, and R.K. Vihko Human 17β-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression Biochem. J. 314 1996 839 845
29. M. Miettinen, M. Mustonen, M. Poutanen, V. Isomaa, M. Wickman, G. Söderqvist, R. Vihko, and P. Vihko 17β-Hydroxysteroid dehydrogenase in normal human mammary epithelial cells and breast tissue Breast Cancer Res. Treat. 57 1999 175 182
30. R. Mindnich, G. Möller, and J. Adamski The role of 17beta-hydroxysteroid dehydrogenases Mol. Cell. Endocrinol. 218 2004 7 20
31. Y. Miyoshi, A. Ando, S. Hasegawa, M. Ishitobi, T. Taguchi, Y. Tamaki, and S. Noguchi High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer Clin. Cancer Res. 9 2003 2288 2293
32. M.V. Mustonen, M.H. Poutanen, S. Kellokumpu, Y. de Launoit, V.V. Isomaa, R.K. Vihko, and P.T. Vihko Mouse 17β-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts J. Mol. Endocrinol. 20 1998 67 74
33. M.V. Mustonen, V.V. Isomaa, T. Vaskivuo, J. Tapanainen, M.H. Poutanen, F. Stenbäck, R.K. Vihko, and P.T. Vihko Human 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle J. Clin. Endocrinol. Metab. 83 1998 1319 1324
34. O. Mäentausta, H. Peltoketo, V. Isomaa, P. Jouppila, and R. Vihko Immunological measurement of human 17β-hydroxysteroid dehydrogenase J. Steroid Biochem. 36 1990 673 680
35. S. Nandi, R.C. Guzman, and J. Yang Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis Proc. Natl. Acad. Sci. U.S.A. 92 1995 3650 3657
36. O.O. Oduwole, V.V. Isomaa, P.A. Nokelainen, F. Stenbäck, and P.T. Vihko Downregulation of estrogen-metabolizing 17β-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer development Int. J. Cancer 97 2002 1 6
37. O.O. Oduwole, M.J. Mäkinen, V.V. Isomaa, A. Pulkka, P. Jernvall, T.J. Karttunen, and P.T. Vihko 17β-hydroxysteroid dehydrogenate type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancer J. Steroid Biochem. Mol. Biol. 87 2003 133 140
38. O.O. Oduwole, Y. Li, V.V. Isomaa, A. Mäntyniemi, A.E. Pulkka, Y. Soini, and P.T. Vihko 17β-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer Cancer Res. 64 2004 7604 7609
39. J.R. Pasqualini, and G.S. Chetrite The selective estrogen enzyme modulators (SEEM) in breast cancer J.R. Pasqualini Breast cancer. Prognosis, treatment, and prevention 2002 Marcel Dekker Inc. New York 187 249
40. H. Peltoketo, P. Vihko, and R. Vihko Regulation of estrogen action: role of 17β-hydroxysteroid dehydrogenases Vitam. Horm. 55 1999 353 398
41. H. Peltoketo, V. Isomaa, D. Ghosh, and P. Vihko Estrogen metabolism genes: HSD17B1 and HSD17B2 B.E. Henderson B. Bonner R.K. Ross Hormones, Genes, and Cancer 2003 Oxford University Press 181 198
42. T.M. Penning, M.E. Burczynski, J.M. Jez, H.K. Lin, H. Ma, M. Moore, K. Ratnam, and N. Palackal Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) Mol. Cell. Endocrinol. 171 2001 137 149
43. M. Poutanen, V. Isomaa, V.P. Lehto, and R. Vihko Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue Int. J. Cancer 50 1992 386 390
44. M. Poutanen, V. Isomaa, H. Peltoketo, and R. Vihko Role of 17β-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis J. Steroid Biochem. Mol. Biol. 55 1995 525 532
45. T. Puranen, M. Poutanen, D. Ghosh, R. Vihko, and P. Vihko Origin of substrate specificity of human and rat 17β-hydroxysteroid dehydrogenase type 1, using chimeric enzymes and site-directed substitutions Endocrinology 138 1997 3532 3539
46. D.W. Russel, and J.D. Wilson Steroid 5-α-reductase: Two genes/two isoenzymes Annu. Rev. Biochem. 63 1994 25 61
47. J. Russo, C. Grill, and I.H. Russo Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland Breast Cancer Res. Threat. 53 1999 217 227
48. H. Sasano, A.R. Frost, R. Saitoh, N. Harada, M. Poutanen, R. Vihko, S.E. Bulun, S.G. Silverberg, and H. Nagura Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma J. Clin. Endocrinol. Metab. 81 1996 4042 4046
49. C. Sawetawan, L. Milewich, A. Word, B.C. Carr, and W.E. Rainey Compartmentalization of type 1 17β-hydroxysteroid oxidoreductase in the human ovary Mol. Cell. Endocrinol. 99 1994 161 168
50. V. Speirs, A.R. Green, and S.L. Atkin Activity and gene expression of 17β-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8 J. Steroid Biochem. Mol. Biol. 67 1998 267 274
51. T. Suzuki, T. Moriya, A. Ariga, C. Kaneko, M. Kanazawa, and H. Sasano 17β-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: correlation to clinicopathological parameters Brit. J. Cancer 82 2000 518 523
52. P.G. Toniolo, M. Levitz, A. Zeleniuch-Jacquotte, S. Bajernee, K.L. Koenig, R.E. Shore, P. Strax, and B.S. Pasternack A prospective study of endogenous estrogens and breast cancer in postmenopausal women J. Natl. Cancer Inst. 87 1995 190 197
53. S. Törn, P. Nokelainen, R. Kurkela, A. Pulkka, M. Menjivar, S. Ghosh, M. Coca-Prados, H. Peltoketo, V. Isomaa, and P. Vihko Production, purification, and functional analysis of recombinant human and mouse 17β-hydroxysteroid dehydrogenase type 7 Biochem. Biophys. Res. Commun. 305 2003 37 45
54. A. Vermeulen, J.P. Deslypere, R. Paridaens, G. Leclercq, F. Roy, and C. Heuson Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women Eur. J. Cancer Clin. Oncol. 22 1986 515 525
55. R. Vihko, and D. Apter Endogenous steroids in the pathophysiology of breast cancer CRC Crit. Rew. Oncol/Hematol. 9 1989 1 15